Also

Elan Corp. and American Home Products Corp. stopped work on an Alzheimer’s treatment after 15 patients developed inflammation of the central nervous system. Although no more patients will receive AN-1792, the companies said they would continue to work on other experimental Alzheimer’s drugs.